merck &amp co new jersey appeals court revives proposed vioxx class action suit a new jersey appeals court has given new life to a proposed class action lawsuit that seeks to force merck &amp co to pay for medical surveillance tests for people who took vioxx but havent yet been diagnosed with health problems merck withdrew the vioxx painkiller from the market after a study showed that it elevated the risk of cardiovascular events a state court judge had dismissed the proposed class action in but in a ruling posted online yesterday the superior court of new jerseys appellate division reversed the lower court ruling and sent the case back to the trial judge for further proceedings in a statement merck attorney ted mayer said "the appellate court did not endorse the plaintiffs position nor did it reject mercks position on the law it simply stated that the lower court order dismissing the complaint was premature " 
